Autres langues Immuron Limited Nasdaq

Actions

Marché Fermé - Nasdaq Autres places de cotation 22:30:00 25/06/2024			Varia. 5j.	Varia. 1 janv.
2,5 ^USD	0,00%		+17,92%	+33,33%

05/06	Immuron Limited nomme Jeannette Joughin au poste d'administrateur	CI
31/05	Immuron Limited annonce la démission de Roger Aston en tant qu'administrateur non exécutif	CI

Immuron Limited Appoints Jeannette Joughin as Director	05/06
Immuron CEO, Steven Lydeamore to present at the Emerging Growth Conference	05/06
Immuron CEO, Steven Lydeamore to present at the Emerging Growth Conference	05/06
Immuron Board Changes	31/05
Immuron CEO Steven Lydeamore to present at Peak Sky High	31/05
Immuron Limited Announces Resignation of Roger Aston as Non-Executive Director	31/05
Immuron Limited to Present at the Emerging Growth Conference	07/05
Immuron Director Resignation	03/05
Immuron Director Resignation	03/05
Immuron Limited Announces Stephen Anastasiou Has Resigns as Non-Executive Director	03/05
Immuron to host Live Virtual Event	15/04
Immuron Travelan® sales continued strong growth	10/04
Immuron Limited Provides Sales Results for the Quarter and Year to Date Ended March 2024	10/04
Immuron's Global Sales Climb 51% in March Quarter; Shares Surge 18%	10/04
Sector Update: Health Care Stocks Gain Late Afternoon	07/03
Sector Update: Health Care	07/03
Top Midday Gainers	07/03
Top Premarket Gainers	07/03
Immuron Moving Anti-Diarrhea Drug to Phase Three Trials	07/03
Immuron Announces Positive Results Support Travelan® progress to Phase 3 Clinical Trials in the US	07/03

Aucun résultat pour cette recherche